organization · Reporting owner

Truffle Capital S.A.S.

Disclosed activity across 1 company

Tapewire entity: 169319
SEC CIK: 0001706034

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Altimmune, Inc.ALT · Entity 5349	10% owner	February 13, 2018	February 15, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Altimmune, Inc.

Report date February 13, 2018 · Filed February 15, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	174,944	Reported balance After 2018-02-13 transaction · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · 2018-02-13 · Other · Acquired 17,789 · Balance 174,944 F1: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund.
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	133,207	Reported balance After 2018-02-13 transaction · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · 2018-02-13 · Other · Acquired 23,719 · Balance 133,207 F1: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4: Held directly by UFF Innovation 15 FCPI, a FCPI.
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	72,217	Reported balance After 2018-02-13 transaction · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · 2018-02-13 · Other · Acquired 17,789 · Balance 72,217 F1: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5: Held directly by Truffle Fortune 4 FCPI, a FCPI.
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	179,427	Reported balance After 2018-02-15 transaction · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · 2018-02-15 · Other · Acquired 4,483 · Balance 179,427 F6: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2408 per share of Common Stock. F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund.
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	139,184	Reported balance After 2018-02-15 transaction · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · 2018-02-15 · Other · Acquired 5,977 · Balance 139,184 F6: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2408 per share of Common Stock. F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4: Held directly by UFF Innovation 15 FCPI, a FCPI.
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	76,700	Reported balance After 2018-02-15 transaction · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · 2018-02-15 · Other · Acquired 4,483 · Balance 76,700 F6: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2408 per share of Common Stock. F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5: Held directly by Truffle Fortune 4 FCPI, a FCPI.
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	416,043	Reported balance Holding disclosure · report date 2018-02-13 · row 7 Holding and transaction disclosures are not merged. 1 source row Row 7 · Balance 416,043 F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F7: Held directly by UFF Innovation 5 (UFF5) FCPI, a FCPI.
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	230,103	Reported balance Holding disclosure · report date 2018-02-13 · row 8 Holding and transaction disclosures are not merged. 1 source row Row 8 · Balance 230,103 F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F8: Held directly by UFF Innovation 17 FCPI, a FCPI.
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	183,690	Reported balance Holding disclosure · report date 2018-02-13 · row 9 Holding and transaction disclosures are not merged. 1 source row Row 9 · Balance 183,690 F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F9: Held directly by Truffle Cap II (TCII) FCPR, a FCPR (Fonds Commun de Placement a Risque), which is a French venture capital fund for institutional subscribers.
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	179,359	Reported balance Holding disclosure · report date 2018-02-13 · row 10 Holding and transaction disclosures are not merged. 1 source row Row 10 · Balance 179,359 F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F10: Held directly by Truffle Fortune 6 FCPI, a FCPI.
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	151,441	Reported balance Holding disclosure · report date 2018-02-13 · row 11 Holding and transaction disclosures are not merged. 1 source row Row 11 · Balance 151,441 F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F11: Held directly by UFF Innovation 16 FCPI, a FCPI.
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	116,654	Reported balance Holding disclosure · report date 2018-02-13 · row 12 Holding and transaction disclosures are not merged. 1 source row Row 12 · Balance 116,654 F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F12: Held directly by Truffle Fortune 5 FCPI, a FCPI.
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	105,804	Reported balance Holding disclosure · report date 2018-02-13 · row 13 Holding and transaction disclosures are not merged. 1 source row Row 13 · Balance 105,804 F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F13: Held directly by Truffle InnoCroissance 2015 FCPI, a FCPI.
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	1,774	Reported balance Holding disclosure · report date 2018-02-13 · row 14 Holding and transaction disclosures are not merged. 1 source row Row 14 · Balance 1,774 F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F14: Held directly by Europe Innovation 2006 (E106) FCPI, a FCPI.
Common Stock, par value $0.0001SEC Table I · non-derivative	IndirectSee Footnote	1,255	Reported balance Holding disclosure · report date 2018-02-13 · row 15 Holding and transaction disclosures are not merged. 1 source row Row 15 · Balance 1,255 F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F15: Held directly by Europe Innovation 2004 (E104) FCPI, a FCPI.
Series B Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.67 · Expires 2018-08-15	IndirectSee Footnote	113.8297	Reported balance After 2018-02-13 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2018-02-13 · Other · Disposed 22.7661 · Balance 113.8297 F16: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund.
Series B Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.67 · Expires 2018-08-15	IndirectSee Footnote	151.7724	Reported balance After 2018-02-13 transaction · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · 2018-02-13 · Other · Disposed 30.3547 · Balance 151.7724 F16: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4: Held directly by UFF Innovation 15 FCPI, a FCPI.
Series B Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.67 · Expires 2018-08-15	IndirectSee Footnote	113.8297	Reported balance After 2018-02-13 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2018-02-13 · Other · Disposed 22.7661 · Balance 113.8297 F16: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5: Held directly by Truffle Fortune 4 FCPI, a FCPI.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock.

F2: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein.

F3: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund.

F4: Held directly by UFF Innovation 15 FCPI, a FCPI.

F5: Held directly by Truffle Fortune 4 FCPI, a FCPI.

F6: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2408 per share of Common Stock.

F7: Held directly by UFF Innovation 5 (UFF5) FCPI, a FCPI.

F8: Held directly by UFF Innovation 17 FCPI, a FCPI.

F9: Held directly by Truffle Cap II (TCII) FCPR, a FCPR (Fonds Commun de Placement a Risque), which is a French venture capital fund for institutional subscribers.

F10: Held directly by Truffle Fortune 6 FCPI, a FCPI.

F11: Held directly by UFF Innovation 16 FCPI, a FCPI.

F12: Held directly by Truffle Fortune 5 FCPI, a FCPI.

F13: Held directly by Truffle InnoCroissance 2015 FCPI, a FCPI.

F14: Held directly by Europe Innovation 2006 (E106) FCPI, a FCPI.

F15: Held directly by Europe Innovation 2004 (E104) FCPI, a FCPI.

F16: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
February 15, 2018 Filed Feb 15, 2018 21:49 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	4,483	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-18-000203 · edgar.xml · nonDerivative · entry 6 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 76,700 F6 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2408 per share of Common Stock. F6 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2408 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5 · ownership.nature: Held directly by Truffle Fortune 4 FCPI, a FCPI. Read SEC document
February 15, 2018 Filed Feb 15, 2018 21:49 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	5,977	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-18-000203 · edgar.xml · nonDerivative · entry 5 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 139,184 F6 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2408 per share of Common Stock. F6 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2408 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4 · ownership.nature: Held directly by UFF Innovation 15 FCPI, a FCPI. Read SEC document
February 15, 2018 Filed Feb 15, 2018 21:49 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	4,483	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-18-000203 · edgar.xml · nonDerivative · entry 4 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 179,427 F6 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2408 per share of Common Stock. F6 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2408 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3 · ownership.nature: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund. Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:49 UTC	Altimmune, Inc. ALT · Entity 5349	OtherSeries B Convertible Preferred Stock · Derivative	22.7661	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-18-000203 · edgar.xml · derivative · entry 18 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 113.8297 Underlying: Common Stock, par value $0.0001 · 8,527 shares Expires 2018-08-15 F16 · derivative.exercise_price: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5 · ownership.nature: Held directly by Truffle Fortune 4 FCPI, a FCPI. Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:49 UTC	Altimmune, Inc. ALT · Entity 5349	OtherSeries B Convertible Preferred Stock · Derivative	30.3547	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-18-000203 · edgar.xml · derivative · entry 17 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 151.7724 Underlying: Common Stock, par value $0.0001 · 11,369 shares Expires 2018-08-15 F16 · derivative.exercise_price: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4 · ownership.nature: Held directly by UFF Innovation 15 FCPI, a FCPI. Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:49 UTC	Altimmune, Inc. ALT · Entity 5349	OtherSeries B Convertible Preferred Stock · Derivative	22.7661	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-18-000203 · edgar.xml · derivative · entry 16 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 113.8297 Underlying: Common Stock, par value $0.0001 · 8,527 shares Expires 2018-08-15 F16 · derivative.exercise_price: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3 · ownership.nature: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund. Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:49 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	17,789	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-18-000203 · edgar.xml · nonDerivative · entry 3 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 72,217 F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5 · ownership.nature: Held directly by Truffle Fortune 4 FCPI, a FCPI. Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:49 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	23,719	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-18-000203 · edgar.xml · nonDerivative · entry 2 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 133,207 F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4 · ownership.nature: Held directly by UFF Innovation 15 FCPI, a FCPI. Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:49 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	17,789	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-18-000203 · edgar.xml · nonDerivative · entry 1 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 174,944 F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.2798 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3 · ownership.nature: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund. Read SEC document
January 17, 2018 Filed Jan 19, 2018 21:56 UTC	Altimmune, Inc. ALT · Entity 5349	OtherSeries B Convertible Preferred Stock · Derivative	22.7661	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-18-000083 · edgar.xml · derivative · entry 15 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 136.5958 Underlying: Common Stock, par value $0.0001 · 8,527 shares Expires 2018-08-15 F15 · derivative.exercise_price: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.6420 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.6420 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5 · ownership.nature: Held directly by Truffle Fortune 4 FCPI, a FCPI. Read SEC document
January 17, 2018 Filed Jan 19, 2018 21:56 UTC	Altimmune, Inc. ALT · Entity 5349	OtherSeries B Convertible Preferred Stock · Derivative	30.3547	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-18-000083 · edgar.xml · derivative · entry 14 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 182.127 Underlying: Common Stock, par value $0.0001 · 11,369 shares Expires 2018-08-15 F15 · derivative.exercise_price: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.6420 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.6420 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4 · ownership.nature: Held directly by UFF Innovation 15 FCPI, a FCPI. Read SEC document
January 17, 2018 Filed Jan 19, 2018 21:56 UTC	Altimmune, Inc. ALT · Entity 5349	OtherSeries B Convertible Preferred Stock · Derivative	22.7661	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-18-000083 · edgar.xml · derivative · entry 13 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 136.5958 Underlying: Common Stock, par value $0.0001 · 8,527 shares Expires 2018-08-15 F15 · derivative.exercise_price: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.6420 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.6420 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3 · ownership.nature: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund. Read SEC document
January 17, 2018 Filed Jan 19, 2018 21:56 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	11,655	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-18-000083 · edgar.xml · nonDerivative · entry 3 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 54,428 F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.6420 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.6420 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5 · ownership.nature: Held directly by Truffle Fortune 4 FCPI, a FCPI. Read SEC document
January 17, 2018 Filed Jan 19, 2018 21:56 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	15,541	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-18-000083 · edgar.xml · nonDerivative · entry 2 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 109,488 F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.6420 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.6420 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4 · ownership.nature: Held directly by UFF Innovation 15 FCPI, a FCPI. Read SEC document
January 17, 2018 Filed Jan 19, 2018 21:56 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	11,655	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-18-000083 · edgar.xml · nonDerivative · entry 1 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 157,155 F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.6420 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.6420 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3 · ownership.nature: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund. Read SEC document
December 15, 2017 Filed Dec 15, 2017 22:47 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	4,337	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-17-000934 · edgar.xml · nonDerivative · entry 6 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 42,773 F6 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.3910 per share of Common Stock. F6 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.3910 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5 · ownership.nature: Held directly by Truffle Fortune 4 FCPI, a FCPI. Read SEC document
December 15, 2017 Filed Dec 15, 2017 22:47 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	5,784	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-17-000934 · edgar.xml · nonDerivative · entry 5 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 93,947 F6 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.3910 per share of Common Stock. F6 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.3910 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4 · ownership.nature: Held directly by UFF Innovation 15 FCPI, a FCPI. Read SEC document
December 15, 2017 Filed Dec 15, 2017 22:47 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	4,337	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-17-000934 · edgar.xml · nonDerivative · entry 4 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 145,500 F6 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.3910 per share of Common Stock. F6 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.3910 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3 · ownership.nature: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund. Read SEC document
December 13, 2017 Filed Dec 15, 2017 22:47 UTC	Altimmune, Inc. ALT · Entity 5349	OtherSeries B Convertible Preferred Stock · Derivative	22.7661	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-17-000934 · edgar.xml · derivative · entry 18 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 159.3618 Underlying: Common Stock, par value $0.0001 · 8,527 shares Expires 2018-08-15 F16 · derivative.exercise_price: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.4213 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.4213 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5 · ownership.nature: Held directly by Truffle Fortune 4 FCPI, a FCPI. Read SEC document
December 13, 2017 Filed Dec 15, 2017 22:47 UTC	Altimmune, Inc. ALT · Entity 5349	OtherSeries B Convertible Preferred Stock · Derivative	30.3547	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-17-000934 · edgar.xml · derivative · entry 17 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 212.4817 Underlying: Common Stock, par value $0.0001 · 11,369 shares Expires 2018-08-15 F16 · derivative.exercise_price: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.4213 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.4213 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4 · ownership.nature: Held directly by UFF Innovation 15 FCPI, a FCPI. Read SEC document
December 13, 2017 Filed Dec 15, 2017 22:47 UTC	Altimmune, Inc. ALT · Entity 5349	OtherSeries B Convertible Preferred Stock · Derivative	22.7661	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-17-000934 · edgar.xml · derivative · entry 16 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 159.3618 Underlying: Common Stock, par value $0.0001 · 8,527 shares Expires 2018-08-15 F16 · derivative.exercise_price: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.4213 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.4213 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3 · ownership.nature: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund. Read SEC document
December 13, 2017 Filed Dec 15, 2017 22:47 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	16,018	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-17-000934 · edgar.xml · nonDerivative · entry 3 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 38,436 F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.4213 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.4213 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5 · ownership.nature: Held directly by Truffle Fortune 4 FCPI, a FCPI. Read SEC document
December 13, 2017 Filed Dec 15, 2017 22:47 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	21,357	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-17-000934 · edgar.xml · nonDerivative · entry 2 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 88,163 F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.4213 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.4213 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4 · ownership.nature: Held directly by UFF Innovation 15 FCPI, a FCPI. Read SEC document
December 13, 2017 Filed Dec 15, 2017 22:47 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	16,018	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-17-000934 · edgar.xml · nonDerivative · entry 1 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 141,163 F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.4213 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.4213 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3 · ownership.nature: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund. Read SEC document
November 14, 2017 Filed Nov 16, 2017 23:58 UTC	Altimmune, Inc. ALT · Entity 5349	OtherSeries B Convertible Preferred Stock · Derivative	22.7661	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-17-000854 · edgar.xml · derivative · entry 15 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 182.1279 Underlying: Common Stock, par value $0.0001 · 8,527 shares Expires 2018-08-15 F15 · derivative.exercise_price: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.89 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.89 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5 · ownership.nature: Held directly by Truffle Fortune 4 FCPI, a FCPI. Read SEC document
November 14, 2017 Filed Nov 16, 2017 23:58 UTC	Altimmune, Inc. ALT · Entity 5349	OtherSeries B Convertible Preferred Stock · Derivative	30.3547	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-17-000854 · edgar.xml · derivative · entry 14 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 242.8363 Underlying: Common Stock, par value $0.0001 · 11,369 shares Expires 2018-08-15 F15 · derivative.exercise_price: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.89 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.89 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4 · ownership.nature: Held directly by UFF Innovation 15 FCPI, a FCPI. Read SEC document
November 14, 2017 Filed Nov 16, 2017 23:58 UTC	Altimmune, Inc. ALT · Entity 5349	OtherSeries B Convertible Preferred Stock · Derivative	22.7661	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-17-000854 · edgar.xml · derivative · entry 13 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 182.1279 Underlying: Common Stock, par value $0.0001 · 8,527 shares Expires 2018-08-15 F15 · derivative.exercise_price: The Issuer's Preferred Stock is convertible at any time at the option of the holder into shares of the Issuer's Common Stock, subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.89 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.89 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3 · ownership.nature: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund. Read SEC document
November 14, 2017 Filed Nov 16, 2017 23:58 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	12,030	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-17-000854 · edgar.xml · nonDerivative · entry 3 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 22,418 F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.89 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.89 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5 · ownership.nature: Held directly by Truffle Fortune 4 FCPI, a FCPI. Read SEC document
November 14, 2017 Filed Nov 16, 2017 23:58 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	16,039	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-17-000854 · edgar.xml · nonDerivative · entry 2 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 66,806 F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.89 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.89 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4 · ownership.nature: Held directly by UFF Innovation 15 FCPI, a FCPI. Read SEC document
November 14, 2017 Filed Nov 16, 2017 23:58 UTC	Altimmune, Inc. ALT · Entity 5349	OtherCommon Stock, par value $0.0001	12,030	Not disclosed	Not disclosed	Disclosure SEC source: 0001012975-17-000854 · edgar.xml · nonDerivative · entry 1 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 125,145 F1 · kind: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.89 per share of Common Stock. F1 · price: Pursuant to the terms of the Series B Convertible Preferred Stock (the "Preferred Stock"), the Issuer converted the Preferred Stock into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") at the installment conversion price of $1.89 per share of Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3 · ownership.nature: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund. Read SEC document
August 21, 2017 Filed Aug 23, 2017 20:23 UTC	Altimmune, Inc. ALT · Entity 5349	PurchaseWarrant · Derivative	30,696	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-17-000652 · edgar.xml · derivative · entry 6 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 30,696 Underlying: Common Stock, par value $0.0001 · 30,696 shares Expires 2022-08-15 F6 · price: Warrants to purchase shares of the Issuer's Common Stock were acquired in connection with the acquisition of the Preferred Stock and reported on this Form 4. The Warrants may not be exercised if such exercise would cause the holder, together with its affiliates, to hold more than 19.99% of the Issuer's Common Stock, prior to the receipt by the Issuer of the Requisite Stockholder Approval. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5 · ownership.nature: Held directly by Truffle Fortune 4 FCPI, a FCPI. Read SEC document
August 21, 2017 Filed Aug 23, 2017 20:23 UTC	Altimmune, Inc. ALT · Entity 5349	PurchaseWarrant · Derivative	40,927	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-17-000652 · edgar.xml · derivative · entry 5 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 40,927 Underlying: Common Stock, par value $0.0001 · 40,927 shares Expires 2022-08-15 F6 · price: Warrants to purchase shares of the Issuer's Common Stock were acquired in connection with the acquisition of the Preferred Stock and reported on this Form 4. The Warrants may not be exercised if such exercise would cause the holder, together with its affiliates, to hold more than 19.99% of the Issuer's Common Stock, prior to the receipt by the Issuer of the Requisite Stockholder Approval. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4 · ownership.nature: Held directly by UFF Innovation 15 FCPI, a FCPI. Read SEC document
August 21, 2017 Filed Aug 23, 2017 20:23 UTC	Altimmune, Inc. ALT · Entity 5349	PurchaseWarrant · Derivative	30,696	Not disclosed Strike: $2.67	Not disclosed	Disclosure SEC source: 0001012975-17-000652 · edgar.xml · derivative · entry 4 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 30,696 Underlying: Common Stock, par value $0.0001 · 30,696 shares Expires 2022-08-15 F6 · price: Warrants to purchase shares of the Issuer's Common Stock were acquired in connection with the acquisition of the Preferred Stock and reported on this Form 4. The Warrants may not be exercised if such exercise would cause the holder, together with its affiliates, to hold more than 19.99% of the Issuer's Common Stock, prior to the receipt by the Issuer of the Requisite Stockholder Approval. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3 · ownership.nature: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund. Read SEC document
August 21, 2017 Filed Aug 23, 2017 20:23 UTC	Altimmune, Inc. ALT · Entity 5349	PurchaseSeries B Convertible Preferred Stock · Derivative	204.894	$940.00 Strike: $2.67	$192,600.36	Disclosure SEC source: 0001012975-17-000652 · edgar.xml · derivative · entry 3 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 204.894 Underlying: Common Stock, par value $0.0001 · 76,740 shares Expires 2018-08-15 F1 · derivative.exercise_price: The Issuer's Series B Convertible Preferred Stock (the "Preferred Stock") is convertible at any time at the option of the holder into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"), subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. Prior to the receipt of approval by the Issuer's stockholders for the issuance of shares pursuant to the conversion of the Preferred Stock (the "Requisite Stockholder Approval"), the Preferred Stock may not be converted by the holder if, as a result of such conversion, the holder, together with its affiliates, would hold more than 19.99% of the Issuer's Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F5 · ownership.nature: Held directly by Truffle Fortune 4 FCPI, a FCPI. Read SEC document
August 21, 2017 Filed Aug 23, 2017 20:23 UTC	Altimmune, Inc. ALT · Entity 5349	PurchaseSeries B Convertible Preferred Stock · Derivative	273.191	$940.00 Strike: $2.67	$256,799.54	Disclosure SEC source: 0001012975-17-000652 · edgar.xml · derivative · entry 2 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 273.191 Underlying: Common Stock, par value $0.0001 · 102,318 shares Expires 2018-08-15 F1 · derivative.exercise_price: The Issuer's Series B Convertible Preferred Stock (the "Preferred Stock") is convertible at any time at the option of the holder into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"), subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. Prior to the receipt of approval by the Issuer's stockholders for the issuance of shares pursuant to the conversion of the Preferred Stock (the "Requisite Stockholder Approval"), the Preferred Stock may not be converted by the holder if, as a result of such conversion, the holder, together with its affiliates, would hold more than 19.99% of the Issuer's Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F4 · ownership.nature: Held directly by UFF Innovation 15 FCPI, a FCPI. Read SEC document
August 21, 2017 Filed Aug 23, 2017 20:23 UTC	Altimmune, Inc. ALT · Entity 5349	PurchaseSeries B Convertible Preferred Stock · Derivative	204.894	$940.00 Strike: $2.67	$192,600.36	Disclosure SEC source: 0001012975-17-000652 · edgar.xml · derivative · entry 1 Truffle Capital S.A.S. · CIK 0001706034 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 204.894 Underlying: Common Stock, par value $0.0001 · 76,740 shares Expires 2018-08-15 F1 · derivative.exercise_price: The Issuer's Series B Convertible Preferred Stock (the "Preferred Stock") is convertible at any time at the option of the holder into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"), subject to certain restrictions, at an initial conversion price of $2.67 per share and a stated amount of $1,000 per share. Prior to the receipt of approval by the Issuer's stockholders for the issuance of shares pursuant to the conversion of the Preferred Stock (the "Requisite Stockholder Approval"), the Preferred Stock may not be converted by the holder if, as a result of such conversion, the holder, together with its affiliates, would hold more than 19.99% of the Issuer's Common Stock. F2 · ownership.nature: Truffle Capital S.A.S., a French societe par actions simplifiee, is the fund manager for each of the funds listed in the following footnotes and as such manages and controls all voting and dispositive rights to shares held by each such fund. Philippe Pouletty, Bernard-Louis Roques and Henri Moulard may be deemed to possess voting and dispositive control over the shares held by funds managed by Truffle Capital S.A.S. and may be deemed to have indirect beneficial ownership of such shares. Each of these individuals disclaims beneficial ownership of such shares, except with respect to any pecuniary interest therein. F3 · ownership.nature: Held directly by UFF Innovation 14 FCPI, a FCPI (Fonds Commun de Placement dans l'Innovation), which is a tax efficient French collective investment fund. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.